Local News

• Corn farmers who use Monsanto advanced technology eligible for lower insurance premiums  Farmers in 11 states who plant a majority of their corn acres using hybrid seeds featuring YieldGard Plus with Roundup Ready Corn 2, YieldGard VT Triple and YieldGard VT Triple PRO technology from Monsanto Company will have an opportunity to lower their crop insurance premiums in 2009.
  Monsanto Company August 19, 2008  
• Patient side point-of-care testing enables quicker treatment decisions  Patient side point-of-care testing - where diagnostic testing is conducted at or near the site of the patient - enables doctors to make decisions on patients presenting with chest pain up to 20 minutes faster than those whose lab tests are evaluated by a standard lab.
  Abbott August 19, 2008  
• BMS and PDL BioPharma enter alliance to develop novel treatment for multiple myeloma  Bristol-Myers Squibb Company and PDL BioPharma announced an agreement for the global development and commercialization of PDL BioPharma's anti-CS1 antibody, elotuzumab, previously known as HuLuc63, currently in Phase I development for multiple myeloma.
  Bristol-Myers Squibb Company August 19, 2008  
• Abbott and AstraZeneca expand relationship to include co-promotion of CRESTOR(R)  Abbott and AstraZeneca announced that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR(R) (rosuvastatin calcium), a medication used along with diet to reduce high cholesterol.
  Abbott August 14, 2008  
• Pfizer says vacation with your dog before the summer ends  With canine motion sickness the leading reason pet owners are not able to take their dogs on day trips or vacation, Pfizer is encouraging more people to talk with their veterinarians about managing travel with their dog before the summer ends.
  Pfizer Inc. August 14, 2008  
• Genentech rejects takeover bid from Roche  Roche is expected to increase its offer for the biotechnology company Genentech now that an initial $43.7 billion bid has been rejected, analysts said. Genentech said that a special committee of directors had found that Roche's offer "substantially undervalues the company."
  The New York Times August 13, 2008  Andrew Pollack
• Bayer’s annual report receives international praise  Praise all around for Bayer's Annual Report 2007: It received gold, silver, bronze and honors twice each in the recently concluded Annual Report Competition (ARC).
  Bayer August 12, 2008  
• Inhibitex reports second quarter 2008 financial results and highlights  Inhibitex announced its financial results for the second quarter ended June 30, 2008. The Company reported that it held $41.9 million in cash, cash equivalents, short-term and long-term investments as of June 30, 2008, as compared to $50.3 million at December 31, 2007.
  Inhibitex, Inc. August 12, 2008  
• Monsanto is extending its industry leadership through 2012  Monsanto is in a position between 2008 and 2012 to launch game-changing technologies, widen its competitive lead, and create even greater growth from seeds and traits as it brings greater yield to farmers around the world, Hugh Grant, Monsanto's chairman, CEO and president, will tell investors.
  Montano Company August 12, 2008  
• Albemarle promotes Dr. David Clary to Vice President, Chief Sustainability Officer  Albemarle has promoted Dr. David Clary to the newly created position of vice president and chief sustainability officer. The new role combines the activities of Albemarle's technology and consumer advocacy functions to reinforce the organization's commitment to a sustainable business model.
  Albemarle Corporation August 12, 2008  

   (next 10 articles)